2m 2m 2m 2m 2m 2m 2m
Qrons (QRON)
OTC
$0.01-$0.00010 (-0.89%)
Price as of May 27, 2026- $198,856.00Market Cap
- -92.07%1-Year Change
- BiotechnologyIndustry
Qrons (QRON)
$0.01-$0.00010 (-0.89%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.01
$0.01
$0.01
1-Year Range
$0.01
$0.14
$0.01
Latest Close$0.01
Change
-$0.00010 (-0.90%)
Volume100
Market Cap$198,856.00
Shares Outstanding17.9M
P/E (TTM)-2.71
Diluted EPS (TTM)-$0.004
Enterprise Value$494,197.00
Information as of 05/27/2026
Company Profile
Qrons Inc.
https://www.firstpersongroup.com$198,856.00
Market Cap
-$56,097.00
Net Income
Sector: Healthcare
Industry: Biotechnology
444 ? 5th Avenue SW, Calgary, AB, Canada, T2P 2T8
587 577 9261First Person Ltd., through its subsidiaries, engages in the formulation and distribution of wholesale food grade functional mushrooms and cognitive performance products focusing on the mental performance and wellness markets in the United States. It focuses on the research and development of psilocybin mushrooms. The company is headquartered in Calgary, Canada.
Key Executives
- Cory J. Rosenberg
- Robert C. Kaelin
- Chris Claussen
Current Ownership Distribution
- Other17.3M (96.18%)
- Insiders687,500 (3.82%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)